课题基金 / 基金详情

CASCADE ROLLING CIRCLE AMPLIFICATION FOR DNA DIAGNOSTICS

CASCADE ROLLING CIRCLE AMPLIFICATION FOR DNA DIAGNOSTICS
用于 DNA 诊断的级联滚环放大
批准号:
2538806
负责人:
David D Thomas
金额:
$9.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1998-03-31

项目摘要

项目成果

David D Thomas的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Many current nucleic acid amplification systems for detecting pathogenic agents may not yield consistent results because optimal amplification conditions vary with each target sequence. Cascade rolling circle amplification (CRCA) is a novel isothermal amplification system that uses generic primers to amplify circularized probes instead of the target. It is rapid, highly sensitive, and easily multiplexed, consistently yielding over a billion-fold amplification within one hour without using a thermocycler. If one of the primers is an energy transfer-labeled primer, homogeneous fluorescence detection of the CRCA product is possible within a closed system. The speed and ease of the assay make this technology suitable for field work or use in developing countries, as well as for simpler automation in diagnostic applications. The feasibility of this system has been demonstrated in preliminary experiments. Phase I objectives include optimization of ligation and amplification conditions to achieve maximum signal strength and sensitivity, and optimization of energy transfer-labeled primer structures that yield the highest fluorescence signal to background ratio without compromising amplification efficiency. The speed and sensitivity of the proposed method will be compared with traditional techniques using a pathogenic target Phase II studies will focus on clinical applications of this system. Proposed commercial applications: This amplification and detection system can form the basis of any DNA diagnostic procedure where the presence or absence of a specific nucleic and target sequence is determined, such as an infectious disease agent, inherited germline mutation, or somatic mutation in a cancer screening test The assay is highly sensitive, fast and simple, and we estimate that it will be less costly than current methods. Because it can be performed in a closed system, false-positive results from carry-over contamination will be minimized. The system is readily amenable to simple automation.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1043/1543-2165-123.20.1170
发表时间: 2009-10
期刊: Archives of pathology & laboratory medicine
影响因子: 4.6
作者: [David C. Thomas;G. Nardone;S. Randall]
通讯作者: David C. Thomas;G. Nardone;S. Randall
High-throughput screen to discover SERCA activators for heart failure therapy
  • 批准号:
    8448939
  • 项目类别:
  • 资助金额:
    $22.8万
  • 财政年份:
    2012
  • 负责人:
    David D Thomas
  • 依托单位:
High-throughput screen to discover SERCA activators for heart failure therapy
  • 批准号:
    8545666
  • 项目类别:
  • 资助金额:
    $17.96万
  • 财政年份:
    2012
  • 负责人:
    David D Thomas
  • 依托单位:
Dystrophic Mouse Colony and Force Assessment
  • 批准号:
    8379536
  • 项目类别:
  • 资助金额:
    $13.25万
  • 财政年份:
    2012
  • 负责人:
    David D Thomas
  • 依托单位:
Spectroscopic Probes of the Muscle Cytoskeleton
  • 批准号:
    8401598
  • 项目类别:
  • 资助金额:
    $34.2万
  • 财政年份:
    2012
  • 负责人:
    David D Thomas
  • 依托单位: